About the Authors
- Nava Siegelmann-Danieli
-
* E-mail: danieli_na@mac.org.il
Affiliation Department of Professional Medicine, Maccabi Healthcare Services, Tel Aviv, Israel
- Ariel Farkash
-
Affiliation Department of Biomedical Informatics, IBM Research-Haifa, Haifa University Campus, Haifa, Israel
- Itzhak Katzir
-
Affiliation Department of Pharmacology, Maccabi Healthcare Services, Tel Aviv, Israel
- Janet Vesterman Landes
-
Affiliation Department of Pharmacology, Maccabi Healthcare Services, Tel Aviv, Israel
- Hadas Rotem Rabinovich
-
Affiliation Department of Pharmacology, Maccabi Healthcare Services, Tel Aviv, Israel
- Yossef Lomnicky
-
Affiliation Department of Pharmacology, Maccabi Healthcare Services, Tel Aviv, Israel
- Boaz Carmeli
-
Affiliation Department of Biomedical Informatics, IBM Research-Haifa, Haifa University Campus, Haifa, Israel
- Naama Parush-Shear-Yashuv
-
Affiliation Department of Biomedical Informatics, IBM Research-Haifa, Haifa University Campus, Haifa, Israel
Competing Interests
Ariel Farkash, Boaz Carmeli, and Naama Parush-Shear-Yashuv are employed by IBM Research-Haifa. IBM invests in analytic and decision support tools for healthcare in general, and specifically for oncology care. The tool described in the paper was developed under research collaboration between IBM and Maccabi Healthcare Services, as well as with other healthcare institutions. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. All other authors declare no conflict of interest.
Author Contributions
Conceived and designed the experiments: NSD AF IK BC. Performed the experiments: AF JVL NPSY. Analyzed the data: NSD AF IK JVL HR YL BC NPSY. Contributed reagents/materials/analysis tools: AF BC NPSY. Wrote the paper: NSD IK NPSY.